scholarly journals Correction of Iron Deficiency in the Cardiorenal Syndrome

2011 ◽  
Vol 2011 ◽  
pp. 1-8 ◽  
Author(s):  
Donald S. Silverberg ◽  
Dov Wexler ◽  
Adrian Iaina ◽  
Doron Schwartz
Keyword(s):  
Iron Deficiency ◽  
Energy Production ◽  
Independent Risk Factor ◽  
Cardiorenal Syndrome ◽  
Safety And Efficacy ◽  
Iv Iron ◽  
Impaired Energy Metabolism ◽  
Long Term Studies

Impaired energy metabolism is a feature of Congestive Heart Failure (CHF). Iron deficiency has been shown to reduce energy production in the cell in animals and humans. Iron deficiency is common in both Chronic Kidney Disease (CKD) and in CHF. Recent studies suggest that iron deficiency is an independent risk factor for mortality in CHF. Studies of correction of the anemia with intravenous (IV) iron in both CKD and CHF have shown an improvement in the anemia and, in some cases, in the renal function as well. Some CHF studies of correction of the iron deficiency have shown an improvement in cardiac function and structure as well as in exercise capacity and quality of life. This occurred independent of whether or not they had anemia, suggesting that the iron deficiency itself may be independently contributing to the worsening of the CHF and CKD. If future long-term studies confirm the safety and efficacy of IV iron in the treatment of iron deficiency in CKD and CHF, this will become a new addition to the therapeutic armamentarium of the cardiorenal syndrome, and parameters of iron deficiency will become part of the routine measurements performed in both CKD and CHF whether or not the patient is anemic.

A Head-to-Head Comparison of the Safety and Efficacy of Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 5157-5157
Author(s):  
Allen Poma ◽  
Karen Diana ◽  
Justin McLaughlin ◽  
Annamaria Kausz
Keyword(s):  
Iron Deficiency ◽  
Oral Iron ◽  
Iron Sucrose ◽  
Iron Therapy ◽  
Deficiency Anemia ◽  
Safety And Efficacy ◽  
Oral Iron Therapy ◽  
The Us ◽  
Iv Iron ◽  
Iron Replacement

Abstract Abstract 5157 BACKGROUND: Iron replacement therapy is essential for increasing iron stores and raising hemoglobin levels in patients with iron deficiency anemia (IDA). Oral iron supplements have limited absorption and are commonly associated with gastrointestinal (GI) side effects that reduce compliance, resulting in limited increases in hemoglobin. In patients without chronic kidney disease (CKD), oral iron therapy is frequently used to treat IDA. However, when oral iron therapy is unsatisfactory or cannot be tolerated, intravenous (IV) iron therapy may be appropriate. In the US, iron dextrans are the only approved IV iron products indicated for the treatment of IDA in non-CKD patients, and have limitations around convenience because they require a test dose and as many as 10 administrations via a slow infusion; iron dextrans have also been associated with a relatively high rate of serious adverse reactions compared to other IV iron products. Other IV irons, such as iron sucrose and sodium ferric gluconate, are only approved in the US for the treatment of IDA in patients with CKD. Like the iron dextrans, both of these products are limited by administration, requiring 5 to 10 clinic visits for the administration of a full therapeutic dose (1 gram of iron). Feraheme® (ferumoxytol) Injection is an IV iron product approved in the US for the treatment of IDA in adult subjects with CKD. Its carbohydrate coating is designed to minimize immunological sensitivity, and it has less free iron than other IV iron preparations. Ferumoxytol is administered as two IV injections of 510 mg (17 mL) 3 to 8 days apart for a total cumulative dose of 1.02 g. METHODS: To date, there have been a limited number of studies that have examined the safety and efficacy of IV irons in a head-to-head manner for the treatment of IDA, and no study has done so in a large number of subjects or in a broad patient population. AMAG, therefore, has initiated a randomized, controlled trial (ClinicalTrials.gov NCT01114204) to compare ferumoxytol with iron sucrose. Iron sucrose is approved in many countries outside the US for the treatment of IDA in patients intolerant to oral iron therapy, and is considered a safer alternative to IV iron dextran. This open-label trial (n=600) will evaluate the efficacy and safety of a 1.02 g of IV ferumoxytol, administered as 2 doses of 510 mg each, compared with 1.0 g of IV iron sucrose, administered as 5 doses of 200 mg each. Enrolled subjects will have IDA associated with a variety of underlying conditions including abnormal uterine bleeding, GI disorders, cancer, postpartum anemia, and others (eg, nutritional deficiency). Endpoints include changes in hemoglobin and transferrin saturation at Week 5, as well as evaluation of the requirement for erythropoiesis stimulating agent therapy and blood transfusion. Patient reported outcomes instruments will be employed to assess the impact of IV iron therapy on anemia symptoms and health-related quality of life (fatigue, energy, etc). Additionally, detailed information on healthcare utilization will be collected. CONCLUSION In the US, non-CKD patients with IDA who have a history of unsatisfactory oral iron therapy have limited options for iron replacement therapy. Study NCT01114204 will provide novel information comparing the safety and efficacy of two IV iron therapies for the treatment of IDA in a broad patient population. Disclosures: Poma: AMAG Pharmaceuticals, Inc.: Employment. Diana:AMAG Pharmaceuticals, Inc.: Employment. McLaughlin:AMAG Pharmaceuticals, Inc.: Employment. Kausz:AMAG Pharmaceuticals, Inc.: Employment.

scholarly journals Biochemical composition of scab-immune apple fruits varieties (Malus domestica B.) as a valuable component of healthy dietary

2021 ◽  
Vol 30 ◽  
pp. 01018
Author(s):  
Natalia Saveleva ◽  
Nadezhda Borzykh ◽  
Vladislav Chivilev ◽  
Andrey Yushkov ◽  
Aleksander Zemisov ◽  
...  
Keyword(s):  
Malus Domestica ◽  
Biochemical Composition ◽  
Food Production ◽  
Soluble Solids ◽  
Valuable Component ◽  
Apple Varieties ◽  
Apple Fruits ◽  
Long Term Studies

The article presents an analysis of the biochemical composition of apple varieties (Malus domestica B.) with immunity to scab. Domestic and foreign apple varieties are used as research objects. Variability in fruits in the content of ascorbic acid (AA), soluble solids (SDS), P-active compounds, and titratable acids was noted. The high content of AA is noted in Uspenskoe, Skala, Bylina, Flagman, Yubilyar apple varieties. Long-term studies have revealed intervarietal differences in biochemical composition and variation of this trait over the years in apples. Varieties with valuable biochemical composition and immunity to scab can be used in organic food production, as well as in further breeding work to improve the quality of fruits.

The Safety and Efficacy of Zolpidem in Insomniac Patients: A Long-Term Open Study in General Practice

1992 ◽  
Vol 20 (2) ◽  
pp. 162-170 ◽  
Author(s):  
L Maarek ◽  
P Cramer ◽  
P Attali ◽  
J P Coquelin ◽  
P L Morselli
Keyword(s):  
Sleep Onset ◽  
Final Visit ◽  
Sleep Onset Latency ◽  
Safety And Efficacy ◽  
Withdrawal Effects ◽  
Withdrawal Signs ◽  
Qualité Du Sommeil

The safety and efficacy of 10 or 20 mg/day zolpidem, a new hypnotic belonging to the imidazopyridine class, were studied over a 180-day period in 96 patients with sleep disorders. The treatment was continued for a further 180 days by 49 of these patients. Follow-up information from 21 patients who discontinued treatment after 180 days showed no rebound insomnia or withdrawal signs. Efficacy of treatment with respect to reduction of sleep onset latency and number of nocturnal wakenings, and improvement in duration of sleep, quality of sleep and morning wakenings was found in nearly 90% of patients and was maintained in those patients who continued treatment for 360 days. This efficacy was achieved with a stable percentage of patients receiving 10 mg/day and 20 mg/day zolpidem from day 30 to the final visit. Zolpidem, therefore, has been shown to be an effective and safe hypnotic, and to be devoid of rebound and withdrawal effects. La sécurité d'utilisation et l'efficacité du 10 ou 20 mg par jour de zolpidem, un nouvel hypnotique appartenant à la classe des imidazopyridines, ont été étudiées sur une période de 180 jours chez 96 patients souffrant de troubles du sommeil. Le traitement s'est poursuivi pendant 180 jours supplémentaires chez 49 de ces patients. Le suivi de 21 patients ayant cessé le traitement au bout de 180 jours n'a montré ni rebond d'insomnie, ni syndrome de sevrage. L'efficacité du traitement se mesure par la reduction du temp d'endormissement et le nombre de réveils noctures, ainsi que l'amélioration de la durée du sommeil, de la qualité du sommeil et du réveil au matin ont été retrouvés chez près de 90% des patients; ces effets se sont maintenus chez les patients qui ont poursuivi le traitement pendant 360 jours. Cette efficacité a été obtenue pour un pourcentage assez constant de patients qui ont reçu 10 mg par jour de zolpidem, puis 20 mg par jour du 30 ème jour à la fin du traitement. Pour ces raisons, le zolpidem, s'est donc révélé être un hypnotique efficace et sûr, dépourvu d'effets de rebond et de sevrage.

Review of Spirulina/Arthrospira Growth Medium Modifications

2020 ◽  
Vol 850 ◽  
pp. 153-158
Author(s):  
Agnese Stunda-Zujeva
Keyword(s):  
Growth Rate ◽  
Growth Medium ◽  
Growth Media ◽  
Composition Change ◽  
Media Composition ◽  
Nacl Concentration ◽  
Medium Modifications ◽  
Long Term Studies

Nutrients and their content in growth medium significantly affect the growth rate and quality of biomass. This review summaries the latest studies on microalgae Arthrospira spp. and Spirulina spp. growth media. Most of studied growth media are modified Zarrouk’s medium. Detailly discussed are effects of change in some microelement concentration and sources and salinity or NaCl concentration, however there are still lacking studies on microelement role and long-term studies. It should be highlighted that various species and strains of Arthrospira and Spirulina reacts to growth media composition change very differently. There is no single best growth media formulae for all species and strains of Arthrospira/Spirulina. Recycling for few times is possible but content of biomass changes.

scholarly journals Evaluation of efficacy and safety of new high-density dyes for chromovitrectomy

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Valerio Piccirillo ◽  
Sandro Sbordone ◽  
Francesco Sorgente ◽  
Adele Ragucci ◽  
Antonello Iovine ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Central Macular Thickness ◽  
Efficacy And Safety ◽  
Safety And Efficacy ◽  
Macular Surgery ◽  
Ocular Coherence Tomography ◽  
Before And After

AbstractThe purpose of this study is to evaluate the safety and efficacy of two novel heavy dyes for macular surgery: DoubledyneTM and TwinTM. One eye from each of 144 patients undergoing surgery for macular hole or macular pucker was included in the study. The eyes were randomly divided into two groups according to the dye used during surgery. Best correct visual acuity (BCVA), intraocular pressure (IOP) and retinal morphology assessed by ocular coherence tomography (OCT) were evaluated before and 1, 3, 6 and 12 months after surgery. Only one surgeon performed each operation and provided a score ranging from 1 (poor) to 10 (excellent) for quality of staining and comfort in surgery. Statistical analysis was carried out with SPSS to compare parameters before and after surgery and between the two groups. No statistical differences were recorded in quality of staining (p = 0.11), in surgery comfort (p = 0.17) and total time of surgery (p = 0.44) between the two groups. BCVA statistically improved and central macular thickness (CMT) statistically decreased after surgery in both groups (p < 0.05). No toxic dye-related complications or long-term ones affecting the retina were observed in either group. According to this data, although confirmation in further studies with larger populations and longer follow up is required, DoubledyneTM and TwinTM proved to be safe and effective dyes for macular surgery.

scholarly journals Phytopathogenic micromycetes associated with conifers in Middle Siberia

2019 ◽  
pp. 129-151
Author(s):  
В.А. Сенашова ◽  
Е.А. Шилкина ◽  
И.Е. Сафронова
Keyword(s):  
Species Diversity ◽  
Microbial Communities ◽  
Premature Death ◽  
Planting Material ◽  
Taxonomic Groups ◽  
Middle Siberia ◽  
Long Term Studies ◽  
Pathogenic Micromycetes

Микроорганизмы, ассоциированные с растениями, в том числе хвойными, играют важную роль в их жизни, формируя микробные сообщества филлосферы, ризопланы и ризосферы. Условно состав таких комплексов можно разделить на патогенную и сапротрофную части. Знание видового разнообразия патогенов, вызывающих заболевания сеянцев и саженцев хвойных, крайне необходимо специалистам сферы лесовозобновления для коррекции агротехнических мероприятий и контроля качества посадочного материала. Цель данных исследований - изучение видового разнообразия патогенных микромицетов хвойных на территории Средней Сибири как в искусственных, так и естественных насаждениях. Применялись классические и современные методы идентификации патогенов. Приводятся данные по видовому составу патогенных микромицетов хвойных за последние 10 лет. Многолетние исследования видового разнообразия микромицетов хвойных на территории Средней Сибири выявили представителей 36 родов, относящихся к различным систематическим группам: Lophodermium Chevall., Lophodermella Höhn., Cyclaneusma DiCosmo, Peredo et Minte, Gremmenia Korf., Hypodermella Tubeuf, Lirula Darker, Sarea Fr., Herpotrichia Fucke, Gremmeniella M. Morelet, Coleosporium Lév., Chrysomyxa Unger, Melampsora Castagne, Melampsorella J. Schröt., Pucciniastrum G.H. Otth., Cronartium Fr., Typhula (Pers.) Fr., Mucor Fresen., Rhizosphaera L. Mangin et Har, Pestalotia De Not., Sclerophoma Höhn. (телеоморфа - Sydowia Bres.), Stagonospora (Sacc.) Sacc. (= Hendersonia Berk.), Lecanosticta Syd., Dothistroma Hulbary, Fusarium Link, Meria Vuill. (телеоморфа - Rhabdocline Syd.), Phoma Sacc., Didymella Sacc., Alternaria Nees, Cladosporium Link, Rhizoctonia DC., Botrytis P. Micheli ex Pers., Septorioides Quaedvl., Verkley et Crous, Epicoccum Link, Trichothecium Link., Verticillium Nees., Cylindrocarpon Wollenw. (телеоморфа - Neonectria Wollenw). Идентифицированные патогены вызывают преждевременную гибель ассимиляционного аппарата, нарушают деятельность корневой и проводящих систем, снижают качество семян хвойных растений. Microorganisms associated with plants, including conifers, play an important role in their life, forming microbial communities of the phyllosphere, rhizoplane, and rhizosphere. Conventionally, the composition of such complexes can be divided into pathogenic and saprotrophic parts. For specialists involved in reforestation, the knowledge of the species diversity of pathogens that cause diseases of seedlings of conifers is essential for correcting agrotechnical measures and controlling the quality of planting material. The goal of this research is to study the species diversity of pathogenic micromycetes of conifers in the Middle Siberia territory, both in artificial and natural plantings. Such long-term studies found representatives of 36 genera belonging to different taxonomic groups: Lophodermium Chevall., Lophodermella Höhn., Cyclaneusma DiCosmo, Peredo et Minte, Gremmenia Korf., Hypodermella Tubeuf, Lirula Darker, Sarea Fr., Herpotrichia Fucke , Gremmeniella M. Morelet, Coleosporium Lév., Chrysomyxa Unger, Melampsora Castagne, Melampsorella J. Schröt., Pucciniastrum G.H. Otth., Cronartium Fr., Typhula (Pers.) Fr., Mucor Fresen., Rhizosphaera L. Mangin et Har, Pestalotia De Not., Sclerophoma Höhn. (teleomorph - Sydowia Bres.), Stagonospora (Sacc.) Sacc. (= Hendersonia Berk.), Lecanosticta Syd., Dothistroma Hulbary, Meria Vuill.( teleomorph- Rhabdocline Syd.), Phoma Sacc., Didymella Sacc., Alternaria Nees, Cladosporium Link, Rhizoctonia DC., Botrytis P. Micheli ex Pers., Septorioides Quaedvl., Verkley et Crous, Epicoccum Link, Trichothecium Link., Cylindrocarpon Wollenw. (teleomorph - Neonectria Wollenw). The identified pathogens cause premature death of the assimilation apparatus, disrupt the activity of the root and vascular systems, and reduce the quality of coniferous plants seeds.

Safety and efficacy of anterior communicating artery compromise during endovascular coil embolization of adjoining aneurysms

2020 ◽  
Vol 132 (4) ◽  
pp. 1068-1076
Author(s):  
Hyun Ho Choi ◽  
Young Dae Cho ◽  
Dong Hyun Yoo ◽  
Su Hwan Lee ◽  
Eung Koo Yeon ◽  
...  
Keyword(s):  
Coil Embolization ◽  
Independent Risk Factor ◽  
Binary Logistic Regression ◽  
Outcome Data ◽  
Anterior Communicating Artery ◽  
Binary Logistic Regression Analysis ◽  
Safety And Efficacy ◽  
Endovascular Coil Embolization

OBJECTIVEIn the presence of symmetric A1 flow, the safety and efficacy of compromising the anterior communicating artery (ACoA) during coil embolization of ACoA aneurysms has yet to be evaluated. Herein, the authors describe their experience, focusing on procedural safety.METHODSBetween October 2012 and July 2017, 285 ACoA aneurysms with symmetric A1 flows were treated at the authors’ institution by endovascular coil embolization. Clinical and angiographic outcome data were subjected to binary logistic regression analysis.RESULTSACoA compromise was chosen in the treatment of 71 aneurysms (24.9%), which were completely (n = 15) or incompletely (n = 56) compromised. In the remaining 214 lesions, the ACoA was preserved. Although 9 patients (3.2%) experienced procedure-related thromboembolisms (compromised, 4; preserved, 5), all but 1 patient (with ACoA compromise) were asymptomatic. In multivariate analysis, subarachnoid hemorrhage at presentation was the sole independent risk factor for thromboembolism (OR 15.98, p < 0.01), with ACoA compromise being statistically unrelated. In 276 aneurysms (96.8%) with follow-up of > 6 months (mean 20.9 ± 13.1 months, range 6–54 months), recanalization was confirmed in 21 (minor, 15; major, 6). A narrow (≤ 4 mm) saccular neck (p < 0.01) and ACoA compromise (p = 0.04) were independently linked to prevention of recanalization.CONCLUSIONSDuring coil embolization of ACoA aneurysms, the ACoA may be compromised without serious complications if A1 flows are symmetric. This approach may also confer some long-term protection from recanalization, serving as a valid treatment option for such lesions.

Long-term studies of antipsychotic drugs in schizophrenia

1996 ◽  
Vol 11 (3) ◽  
pp. 127-134 ◽  
Author(s):  
T Lewander
Keyword(s):  
Quality Of Life ◽  
Rating Scales ◽  
Assessment Instruments ◽  
Main Concern ◽  
Drug Induced ◽  
Safety Issues ◽  
And Performance ◽  
Long Term Studies

SummaryStudies on long-term efficacy and safety should be a main concern in the evaluation of novel antipsychotics. The present paper is a review of important issues related to the design and performance of such trials. The variability of the natural course of schizophrenia, the variability in treatment response, and the variability of actions of different neuroleptics need to be considered. Long-term studies need to address maintenance of efficacy, prevention of relapse and recurrence, health economics, quality of life and a large number of safety issues in order to get approval for new drug applications and reimbursement on expensive new medicines. Assessment instruments for efficacy, tolerability and safety, need to be supplemented with rating scales for various aspects of psychopathology (positive, negative, deficit symptoms), social and work functioning, drug induced mental side effects, quality of life and accounts of total treatment costs.

Sign in / Sign up

Export Citation Format

Share Document